News Archives - Page 13 of 16 - Halberd Corporation

Nov 25 2020

Halberd Corp. CEO Interviewed on Money TV;
Discusses 2020 Accomplishments and Plans

By Admin|2020-11-24T20:59:01-05:00November 25th, 2020|Featured, Investor News, News|0 Comments

Jackson Center, PA, November 25, 2020 – Halberd Corporation (OTC-PINK: "HALB") Chairman, President and CEO, William A. Hartman, was interviewed this week by host, Donald Baillargeon, on Money TV. Mr. Hartman recapped the company’s accomplishments, describing its most promising technologies and described the unique applications perceived, including a sneak peek at the future. Mr. Hartman ...

Nov 19 2020

Halberd Corporation Files for Patent Protection on Covid-19 Extracorporeal Treatment Variation

By Admin|2020-11-18T19:10:48-05:00November 19th, 2020|Featured, Investor News, News|0 Comments

Jackson Center, PA, November 19, 2020 – Halberd Corp. (OTC PINK: "HALB") reported the filing of a provisional patent application on a variation of Halberd’s patented extracorporeal method to treat/eradicate Covid-19 from a patient’s blood. By using an extracorporeal (outside the body) treatment method, the patient is exposed to far fewer potential negative side effects ...

Nov 16 2020

Halberd Corp. CEO Interviewed on Money TV; Discusses New Fluorescent Covid-19 Antibody

By Admin|2020-11-15T17:29:50-05:00November 16th, 2020|Featured, Investor News, News|0 Comments

Mr. Hartman discusses advantages over existing antibodies. Jackson Center, PA, November 16, 2020 – Halberd Corporation (OTC-PINK: "HALB") Chairman, President and CEO, William A. Hartman, was interviewed recently by host, Donald Baillargeon, on Money TV. In the segment, Mr. Hartman provided information on Halberd’s new patent pending Covid-19 fluorescent antibody. This should allow for rapid ...

Nov 12 2020

Halberd Corporation Reveals Patent-Pending Fluorescent Antibody’s Wide Role in Covid-19 Detection & Treatment

By Admin|2020-11-11T20:25:36-05:00November 12th, 2020|Featured, Investor News, News|0 Comments

Jackson Center, PA, November 12, 2020 – Halberd Corporation (OTC PINK: "HALB") today disclosed information on their patent-pending fluorescent anti-Spike protein monoclonal antibodies against Covid-19 developed in conjunction with Dr. Qiang (Shawn) Chen of Arizona State University. The salient feature of Halberd’s new class of antibody is that it fluoresces in the presence of Covid-19 ...

Nov 9 2020

Halberd Corporation Files for Patent Protection on Enhanced Nasal Spray to Prevent Covid-19

By Admin|2020-11-08T20:54:51-05:00November 9th, 2020|Featured, Investor News, News|0 Comments

Jackson Center, PA, November 9, 2020 – Halberd Corp. (OTC PINK: "HALB") reported the filing of a Covid-19 provisional patent on an enhanced nasal spray. The application, “Nasal Spray to Prevent the Transmission of Covid-19,” discloses a combination of proprietary Covid-19 Spike Protein antibodies, ACE2 antibody, and Neuropilin-1 antibodies. This application builds on, and is ...

Nov 5 2020

Halberd Corp. Develops Second Covid-19 Antibody for Enhanced Nasal Spray and Doubles Performance of New Class of Antibody

By Admin|2020-11-04T20:08:10-05:00November 5th, 2020|Featured, Investor News, News|0 Comments

Jackson Center, PA, November 5, 2020 – Halberd Corporation (OTC PINK: "HALB") reports its research team developed a second monoclonal antibody against Covid-19 SARS 2 disease antigens paving the way for development of a potentially more effective nasal spray. Additionally, Halberd’s continuing work on its new class of antibody doubles the performance capacity of a ...

Nov 2 2020

Halberd Corp. CEO Interviewed on Money TV

By Admin|2020-11-01T21:04:15-05:00November 2nd, 2020|Featured, Investor News, News, Videos|0 Comments

In Case You Missed It - Mr. Hartman discusses recent accomplishments and new opportunities. Jackson Center, PA, November 2, 2020 – Halberd Corporation (OTC-PINK: "HALB") Chairman, President and CEO, William A. Hartman, was interviewed recently by host, Donald Baillargeon, on Money TV. In the segment, Mr. Hartman provided an update on the company’s latest activities, ...

Oct 29 2020

Halberd Corp. Development Efforts Transcend Covid-19 Prevention, Diagnostics & Therapeutics

By Admin|2020-10-28T20:28:05-04:00October 29th, 2020|Featured, Investor News, News|0 Comments

Jackson Center, PA, October 29, 2020 – Halberd Corporation (OTC PINK: "HALB") today provided insight concerning its strategic plans beyond developing unique antibodies which form the basis of their current all-out efforts to generate products and processes to prevent, diagnose and treat Covid-19. These strategic plans are designed to benefit people well after Covid-19 is ...

Oct 27 2020

Halberd Corp. Retains Prestigious Patent Law Firm on Covid-19-Related and Other Disease Technologies

By Admin|2020-10-26T18:49:33-04:00October 27th, 2020|Featured, Investor News, News|0 Comments

Jackson Center, PA, October 27, 2020 – Halberd Corporation (OTC PINK: "HALB") has retained the services of a prestigious Pittsburgh, PA law firm, Ference & Associates, to handle its intellectual property matters. The initial application focuses on patenting Halberd’s base Covid-19 antibody as well as an entire new class of antibody conjugate. The primary attorney ...

Oct 26 2020

ICYMI — Halberd Corporation Discusses The Development of New Class of COVID-19 Antibody with The Stock Day Podcast

By Admin|2020-10-25T21:54:06-04:00October 26th, 2020|Featured, Investor News, News|0 Comments

In Case You Missed It Phoenix, Arizona–(Newsfile Corp. – October 22, 2020) – The Stock Day Podcast welcomed Halberd Corporation (OTC Pink: HALB) (“the Company”), a publicly traded company on the OTC Market, and is in full compliance with OTC Market reporting requirements. CEO of the Company, Bill Hartman, joined Stock Day host Everett Jolly. ...

Previous 121314 Next